ANGPTL3 and hypothyroidism: Additionally, our study also provided suggestive evidence for the potential therapeutic use of ANGPTL3 inhibitors for both hypothyroidism and hyperthyroidism, while showing that LPL activation was related to increasing hyperthyroidism risk.